224 related articles for article (PubMed ID: 17589593)
1. Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men: the VA Normative Aging Study.
Jain NB; Potula V; Schwartz J; Vokonas PS; Sparrow D; Wright RO; Nie H; Hu H
Environ Health Perspect; 2007 Jun; 115(6):871-5. PubMed ID: 17589593
[TBL] [Abstract][Full Text] [Related]
2. The relationship of bone and blood lead to hypertension. The Normative Aging Study.
Hu H; Aro A; Payton M; Korrick S; Sparrow D; Weiss ST; Rotnitzky A
JAMA; 1996 Apr; 275(15):1171-6. PubMed ID: 8609684
[TBL] [Abstract][Full Text] [Related]
3. Prospective cohort study of lead exposure and electrocardiographic conduction disturbances in the Department of Veterans Affairs Normative Aging Study.
Eum KD; Nie LH; Schwartz J; Vokonas PS; Sparrow D; Hu H; Weisskopf MG
Environ Health Perspect; 2011 Jul; 119(7):940-4. PubMed ID: 21414889
[TBL] [Abstract][Full Text] [Related]
4. Low-Level Cumulative Lead and Resistant Hypertension: A Prospective Study of Men Participating in the Veterans Affairs Normative Aging Study.
Zheutlin AR; Hu H; Weisskopf MG; Sparrow D; Vokonas PS; Park SK
J Am Heart Assoc; 2018 Nov; 7(21):e010014. PubMed ID: 30608198
[TBL] [Abstract][Full Text] [Related]
5. Stress as a potential modifier of the impact of lead levels on blood pressure: the normative aging study.
Peters JL; Kubzansky L; McNeely E; Schwartz J; Spiro A; Sparrow D; Wright RO; Nie H; Hu H
Environ Health Perspect; 2007 Aug; 115(8):1154-9. PubMed ID: 17687441
[TBL] [Abstract][Full Text] [Related]
6. Occupational determinants of bone and blood lead levels in middle aged and elderly men from the general community: the Normative Aging Study.
Elmarsafawy SF; Tsaih SW; Korrick S; Dickey JH; Sparrow D; Aro A; Hu H
Am J Ind Med; 2002 Jul; 42(1):38-49. PubMed ID: 12111689
[TBL] [Abstract][Full Text] [Related]
7. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction.
Schuit SC; Oei HH; Witteman JC; Geurts van Kessel CH; van Meurs JB; Nijhuis RL; van Leeuwen JP; de Jong FH; Zillikens MC; Hofman A; Pols HA; Uitterlinden AG
JAMA; 2004 Jun; 291(24):2969-77. PubMed ID: 15213208
[TBL] [Abstract][Full Text] [Related]
9. Bone Lead Levels and Risk of Incident Primary Open-Angle Glaucoma: The VA Normative Aging Study.
Wang W; Moroi S; Bakulski K; Mukherjee B; Weisskopf MG; Schaumberg D; Sparrow D; Vokonas PS; Hu H; Park SK
Environ Health Perspect; 2018 Aug; 126(8):087002. PubMed ID: 30102601
[TBL] [Abstract][Full Text] [Related]
10. Visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study.
Christoffersen M; Frikke-Schmidt R; Schnohr P; Jensen GB; Nordestgaard BG; Tybjærg-Hansen A
Circulation; 2014 Mar; 129(9):990-8. PubMed ID: 24334176
[TBL] [Abstract][Full Text] [Related]
11. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study.
Hu H; Payton M; Korrick S; Aro A; Sparrow D; Weiss ST; Rotnitzky A
Am J Epidemiol; 1996 Oct; 144(8):749-59. PubMed ID: 8857824
[TBL] [Abstract][Full Text] [Related]
12. Bone lead level prediction models and their application to examine the relationship of lead exposure and hypertension in the Third National Health and Nutrition Examination Survey.
Park SK; Mukherjee B; Xia X; Sparrow D; Weisskopf MG; Nie H; Hu H
J Occup Environ Med; 2009 Dec; 51(12):1422-36. PubMed ID: 19952788
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of fatigue for nonfatal ischemic heart disease and all-cause mortality.
Ekmann A; Osler M; Avlund K
Psychosom Med; 2012 Jun; 74(5):464-70. PubMed ID: 22685239
[TBL] [Abstract][Full Text] [Related]
14. Low-level lead exposure, metabolic syndrome, and heart rate variability: the VA Normative Aging Study.
Park SK; Schwartz J; Weisskopf M; Sparrow D; Vokonas PS; Wright RO; Coull B; Nie H; Hu H
Environ Health Perspect; 2006 Nov; 114(11):1718-24. PubMed ID: 17107858
[TBL] [Abstract][Full Text] [Related]
15. Impact of metabolic syndrome on ischemic heart disease - a prospective cohort study in an Iranian adult population: Isfahan Cohort Study.
Talaei M; Sadeghi M; Marshall T; Thomas GN; Kabiri P; Hoseini S; Sarrafzadegan N
Nutr Metab Cardiovasc Dis; 2012 May; 22(5):434-41. PubMed ID: 21195593
[TBL] [Abstract][Full Text] [Related]
16. Lead burden and psychiatric symptoms and the modifying influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism: the VA Normative Aging Study.
Rajan P; Kelsey KT; Schwartz JD; Bellinger DC; Weuve J; Sparrow D; Spiro A; Smith TJ; Nie H; Hu H; Wright RO
Am J Epidemiol; 2007 Dec; 166(12):1400-8. PubMed ID: 17823382
[TBL] [Abstract][Full Text] [Related]
17. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
18. Bone lead levels and blood pressure endpoints: a meta-analysis.
Navas-Acien A; Schwartz BS; Rothenberg SJ; Hu H; Silbergeld EK; Guallar E
Epidemiology; 2008 May; 19(3):496-504. PubMed ID: 18414090
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
Suadicani P; Hein HO; Gyntelberg F
Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
[TBL] [Abstract][Full Text] [Related]
20. Case-cohort study of styrene exposure and ischemic heart disease.
Matanoski GM; Tao X
Res Rep Health Eff Inst; 2002 May; (108):1-29; discussion 31-7. PubMed ID: 12214600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
